CLOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Advanced Biomedical

Advanced Biomedical is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

McBride Orthopedic Hospital

McBride Orthopedic Hospital opened in 2005 as a full-service orthopedic hospital. McBride has grown to include a board-certified physician staff of 28, practicing at five metro locations and several outreach clinics in rural communities. The physicians continue their close involvement with athletes of all ages, serving as team physicians for many of the local professional, collegiate, and high school athletes.

Park View Care Ctr

Park View Care Ctr is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

North Country Health Services

North Country Health Services is a Bemidji, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Framingham Heart Study

Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.